VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FTHFaeth Therapeutics, Inc.
$9.04$568M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFTHQuarterly Financials

Faeth Therapeutics, Inc. (FTH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Faeth Therapeutics, Inc. (FTH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

FTH Income Statement

Quarterly statement

FTH Income Statement

Faeth Therapeutics, Inc. (FTH) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue0000-4.85M000000000000000
Revenue Growth %100%-------------------
Cost of Goods Sold17K0132.96M0-4.85M00139K140K135K137K135K455K491K0469K451K440K448K329K
COGS % of Revenue----100%---------------
Gross Profit-17K0-132.96M0000-139K-140K-135K-137K-135K-455K-491K0-469K-451K-440K-448K-329K
Gross Margin %--------------------
Gross Profit Growth %---100%100%100%-----71.22%-0.89%-11.59%100%-42.55%-231.62%-260.66%-357.14%-
Operating Expenses22.09M18.39M37.67M4.96M4.85M5.21M7.27M7.18M7.68M7.65M8.59M8.01M7.28M9.69M11.01M11.51M13.49M10.27M12.04M9.08M
OpEx % of Revenue-----100%---------------
Selling, General & Admin10.35M9.21M19.71M2.79M2.31M2.67M3.55M2.69M3.05M3.07M3.68M3.51M3.46M5.21M5.8M4.97M4.3M3.88M4.58M3.13M
SG&A % of Revenue-----47.72%---------------
Research & Development11.74M9.18M17.96M2.17M2.54M2.53M3.73M4.49M4.64M4.58M4.92M4.49M3.82M4.48M5.2M6.54M9.19M6.39M7.46M5.96M
R&D % of Revenue-----52.28%---------------
Other Operating Expenses00000000000000000000
Operating Income-22.09M-18.39M-170.63M-4.96M-4.85M-5.21M-7.27M-7.32M-7.82M-7.79M-8.73M-8.14M-7.74M-10.19M-11.01M-11.98M-13.94M-10.71M-12.49M-9.41M
Operating Margin %----100%---------------
Operating Income Growth %-355.29%-253.15%-2245.71%32.31%37.99%33.15%----20.69%32.04%44.5%4.92%11.84%-27.27%-35.14%-9.48%-56.69%-85.4%
EBITDA-22.07M-18.36M-170.6M-4.92M-4.82M-5.17M-7.24M-6.99M-7.49M-7.46M-8.59M-8.01M-7.28M-9.69M-10.65M-11.51M-13.49M-10.27M-12.04M-9.08M
EBITDA Margin %----99.3%---------------
EBITDA Growth %-358.15%-255.21%-2256.31%29.59%35.7%30.7%----19.31%30.44%46.02%5.63%11.54%-26.72%-32.51%-6.31%-52.95%-81.43%
D&A (Non-Cash Add-back)17K24K30K34K34K37K34K331K332K328K137K135K455K491K358K469K451K440K448K329K
EBIT-22.09M-16.01M-170.24M-4.71M-4.56M-4.93M-6.85M-7.75M-7.23M-7.12M-7.96M-7.38M-7.09M-9.35M-10.13M-12.23M-13.41M-10.36M-12.16M-9.06M
Net Interest Income1.78M2.26M392K220K283K311K392K505K570K645K740K795K844K914K927K609K505K177K67K28K
Interest Income1.78M2.26M392K223K289K321K405K522K591K669K768K826K877K952K969K609K515K349K310K334K
Interest Expense0003K6K10K13K17K21K24K28K31K33K38K42K010K172K243K306K
Other Income/Expense1.69M2.38M391K240K282K270K410K-447K570K645K738K728K613K799K831K-252K525K177K82K47K
Pretax Income-20.4M-16.01M-170.24M-4.72M-4.57M-4.94M-6.86M-7.77M-7.25M-7.14M-7.99M-7.41M-7.12M-9.39M-10.18M-12.23M-13.42M-10.54M-12.4M-9.37M
Pretax Margin %----94.19%---------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-20.4M-16.01M-170.24M-4.72M-4.57M-4.94M-6.86M-7.77M-7.25M-7.14M-7.99M-7.41M-7.12M-9.39M-10.18M-12.23M-13.42M-10.54M-12.4M-9.37M
Net Margin %----94.19%---------------
Net Income Growth %-346.44%-224.29%-2380.13%39.29%37.01%30.89%----21.47%39.39%46.9%10.91%17.96%-30.6%-38.52%-7.82%-55.61%-82.54%
Net Income (Continuing)-20.4M-16.01M-170.24M-4.72M-4.57M-4.94M-6.86M-7.77M-7.25M-7.14M-7.99M-7.41M-7.12M-9.39M-10.18M-12.23M-13.42M-10.54M-12.4M-9.37M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.79-2.84-131.45-3.74-3.62-3.91-5.45-6.18-5.77-5.69-0.32-0.30-0.28-0.31-0.33-0.40-0.42-0.34-0.40-0.31
EPS Growth %78.18%27.37%-2311.93%39.48%37.26%31.28%----3.03%25%33.33%8.82%17.5%-29.03%-31.25%-6.25%4.76%-14.81%
EPS (Basic)-0.79-2.84-131.45-3.74-3.62-3.91-5.45-6.18-5.77-5.69-0.32-0.30-0.28-0.31-0.33-0.40-0.42-0.34-0.40-0.31
Diluted Shares Outstanding25.84M5.64M1.3M1.26M1.26M1.26M1.26M1.26M1.26M1.26M25.05M25.03M25.51M30.51M30.87M30.74M30.72M30.7M30.65M30.59M
Basic Shares Outstanding25.84M5.64M1.3M1.26M1.26M1.26M1.26M1.26M1.26M1.26M25.05M25.03M25.51M30.51M30.87M30.74M30.72M30.7M30.65M30.59M
Dividend Payout Ratio--------------------